Etomidate for intubation of patients who have sepsis or septic shock – where do we go from here?

Link to article at PubMed

Etomidate for intubation of patients who have sepsis or septic shock - where do we go from here?

Crit Care. 2012 Dec 27;16(6):189

Authors: Griesdale DE

Abstract

ABSTRACT: Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure. However, etomidate causes adrenal suppression, which itself has been associated with increased mortality in critically ill patients. The ongoing debate surrounding use of etomidate is thus centered on the immediate favorable hemodynamic profile versus the long-term risks of adrenal insufficiency, particularly in patients who have severe sepsis or septic shock.

PMID: 23273139 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.